» Articles » PMID: 37063844

Telomerase Reverse Transcriptase and Neurodegenerative Diseases

Overview
Journal Front Immunol
Date 2023 Apr 17
PMID 37063844
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases (NDs) are chronic conditions that result in progressive damage to the nervous system, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and Amyotrophic lateral sclerosis (ALS). Age is a major risk factor for NDs. Telomere shortening is a biological marker of cellular aging, and telomerase reverse transcriptase (TERT) has been shown to slow down this process by maintaining telomere length. The blood-brain barrier (BBB) makes the brain a unique immune organ, and while the number of T cells present in the central nervous system is limited, they play an important role in NDs. Research suggests that NDs can be influenced by modulating peripheral T cell immune responses, and that TERT may play a significant role in T cell senescence and NDs. This review focuses on the current state of research on TERT in NDs and explores the potential connections between TERT, T cells, and NDs. Further studies on aging and telomeres may provide valuable insights for developing therapeutic strategies for age-related diseases.

Citing Articles

Cellular senescence in Alzheimer's disease: from physiology to pathology.

Zhu J, Wu C, Yang L Transl Neurodegener. 2024; 13(1):55.

PMID: 39568081 PMC: 11577763. DOI: 10.1186/s40035-024-00447-4.


Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition.

Mlakar V, Akkouh I, Halff E, Srivastava D, Birkenaes V, Ueland T Schizophr Res. 2024; 272:89-95.

PMID: 39208769 PMC: 11846775. DOI: 10.1016/j.schres.2024.08.011.


lncRNA signature mediates mitochondrial permeability transition-driven necrosis in regulating the tumor immune microenvironment of cervical cancer.

Yi C, Yang J, Zhang T, Xie Z, Xiong Q, Chen D Sci Rep. 2024; 14(1):17406.

PMID: 39075098 PMC: 11286791. DOI: 10.1038/s41598-024-65990-6.


Regulation of Tert methylation alleviates food allergy via regulating the Tert-IL10 signal pathway.

Zeng H, Xu L, Liu J, Mo L, Li M, Song S Immunol Res. 2024; 72(5):1018-1029.

PMID: 39034374 DOI: 10.1007/s12026-024-09504-6.


Molecular hallmarks of ageing in amyotrophic lateral sclerosis.

Jagaraj C, Shadfar S, Kashani S, Saravanabavan S, Farzana F, Atkin J Cell Mol Life Sci. 2024; 81(1):111.

PMID: 38430277 PMC: 10908642. DOI: 10.1007/s00018-024-05164-9.


References
1.
Jouanne M, Rault S, Voisin-Chiret A . Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents. Eur J Med Chem. 2017; 139:153-167. DOI: 10.1016/j.ejmech.2017.07.070. View

2.
Wan T, Weir E, Johnson M, Korolchuk V, Saretzki G . Increased telomerase improves motor function and alpha-synuclein pathology in a transgenic mouse model of Parkinson's disease associated with enhanced autophagy. Prog Neurobiol. 2020; 199:101953. PMC: 7938226. DOI: 10.1016/j.pneurobio.2020.101953. View

3.
Chen Z, Zhong C . Oxidative stress in Alzheimer's disease. Neurosci Bull. 2014; 30(2):271-81. PMC: 5562667. DOI: 10.1007/s12264-013-1423-y. View

4.
Mietelska-Porowska A, Wojda U . T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers. J Immunol Res. 2017; 2017:4626540. PMC: 5331319. DOI: 10.1155/2017/4626540. View

5.
Svenningsson P, Westman E, Ballard C, Aarsland D . Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 2012; 11(8):697-707. DOI: 10.1016/S1474-4422(12)70152-7. View